Entering text into the input field will update the search result below

Endo under modest pressure on Athenex vasopressin launch, shares down 3%

Aug. 13, 2018 12:26 PM ETEndo International plc (ENDPQ) StockENDPQBy: Douglas W. House, SA News Editor8 Comments
  • Endo International (ENDP -3.3%) slips on below-average volume in apparent reaction to the Athenex's U.S. launch of its generic vasopressin, a diuretic that is Endo's top seller, accounting for almost 15% of its Q2 sales ($106.3/$714.7).
  • Legal action is likely since Endo says compounding of vasopressin should not be allowed.
  • Previously: Athenex launches vasopressin ready-to-use premix IV bags in U.S. (Aug. 13)

Recommended For You

About ENDPQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ENDPQ--
Endo International plc